CoChat

Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease

Sumida, Yoshio, Yonei, Yoshikazu, Tanaka, Saiyu, Mori, Kojiroh, Kanemasa, Kazuyuki, Imai, Shunsuke, Taketani, Hiroyoshi, Hara, Tasuku, Seko, Yuya, Ishiba, Hiroshi, Okajima, Akira, Yamaguchi, Kanji, Moriguchi, Michihisa, Mitsuyoshi, Hironori, Yasui, Kohichiroh, Minami, Masahito, Itoh, Yoshito · 2015 · Hepatology Research
Cited by 86

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aim: Growth hormone (GH) deficiency may be associated with histological progression of non‐alcoholic fatty liver disease (NAFLD) which includes non‐alcoholic fatty liver (NAFL) and non‐alcoholic steatohepatitis (NASH). Insulin‐like growth factor 1 (IGF‐1) is mainly produced by hepatocytes and its secretion is stimulated by GH. Our aim was to determine whether more histologically advanced NAFLD is associated with low circulating levels of IGF‐1 in Japanese patients. Methods: Serum samples were obtained in 199 J apanese patients with biopsy‐proven NAFLD and in 2911 sex‐ and age‐matched healthy people undergoing health checkups. The serum levels of IGF‐1 were measured using a commercially available immunoradiometric assay. The standard deviation scores (SDS) of IGF‐1 according to age and sex were also calculated in NAFLD patients. Results: The serum IGF‐1 levels in NAFLD patients were significantly lower (median, 112 ng/mL) compared with the control population (median, 121 ng/mL,P < 0.0001).IGF‐1 SDS less than −2.0 SD from median were found in 11.6% of 199 patients.NASH patients exhibited significantly lower levels of IGF‐1 SDS(n = 130; median, −0.7) compared with NAFL patients (n = 69; median, −0.3;P = 0.026). The IGF‐1 SDS values decreased significantly with increasing lobular inflammation (P < 0.001) and fibrosis (P < 0.001). In multiple regressions, the association between the IGF‐1 SDS values and the severity of NAFLD persisted after adjusting for age, sex and insulin resistance. Conclusion: Low levels of circulating IGF‐1 may have a role in the development of advanced NAFLD, independent of insulin resistance. Supplementation with GH/IGF‐1 may be a candidate for the treatment of NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hepr.12408

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 86

Metadata

Authors
Sumida, Y., Yonei, Y., Tanaka, S., Mori, K., Kanemasa, K., Imai, S., Taketani, H., Hara, T., Seko, Y., Ishiba, H., Okajima, A., Yamaguchi, K., Moriguchi, M., Mitsuyoshi, H., Yasui, K., Minami, M., & Itoh, Y.
Venue
Hepatology Research
Publisher
Wiley
Published
2014-09-30
Volume
45
Issue
7
Pages
771-781
ISSN
  • 1386-6346 (ISSN-L)
  • 1872-034X
OpenAlex
W2160287140
Cited by
86
References
7
FWCI
5.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1111/hepr.12408
The paper
Sumida, Y., Yonei, Y., Tanaka, S., Mori, K., Kanemasa, K., Imai, S., Taketani, H., Hara, T., Seko, Y., Ishiba, H., Okajima, A., Yamaguchi, K., Moriguchi, M., Mitsuyoshi, H., Yasui, K., Minami, M., & Itoh, Y. (2015). Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease. Hepatology Research. https://doi.org/10.1111/hepr.12408

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.